FDA-Inspected Site

Biofusion Management and Manufacturing, LLC

2 FDA inspections are on record for Biofusion Management and Manufacturing, LLC in Austin, United States.

483· Form 483 issued

Austin, United States · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-02-26.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
24 Feb 2025 – 26 Feb 2025Medical Devices & Rad Health483View 483 →
3 Dec 2019 – 5 Dec 2019Medical Devices & Rad HealthClean

Observations on record

Form 483 observations cited at this site, most recent first.

26 Feb 2025
21 CFR 801.20(a)

Label to bear a unique device identifier

Cited by Daniel J Lahar

26 Feb 2025
21 CFR 820.20(c)

Management review dates

Cited by Daniel J Lahar

26 Feb 2025
21 CFR 820.22

Quality Audit/Reaudit - conducted

Cited by Daniel J Lahar

26 Feb 2025
21 CFR 820.25(b)

Training records

Cited by Daniel J Lahar

26 Feb 2025
21 CFR 820.72(a)

Calibration, Inspection, etc. Procedures Lack of or Inadequ

Cited by Daniel J Lahar

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 801.20(a)Cited across public-safe Form 483 observations1x
21 CFR 820.20(c)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x
21 CFR 830.300(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Biofusion Management and Manufacturing, LLC's 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat